Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia

Conditions: Hyperammonemia Interventions: Drug: TNP-2092 placebo capsules; Drug: TNP-2092 capsules Sponsors: TenNor Therapeutics (Suzhou) Limited Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials